| Quarterly Financials | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 33 | 30 | 93 | 60 | 33 | 122 | 49 | 50 | 43 | 27 | 39 | 30 | 23 | 24 | 35 | 28 | 16 | 26 | 34 | 28 | 34 | 37 | 40 | 42 |
| Expenses | 29 | 17 | 56 | 52 | 28 | 72 | 41 | 43 | 44 | 31 | 42 | 29 | 25 | 24 | 30 | 27 | 21 | 23 | 34 | 31 | 31 | 35 | 35 | 36 |
| EBITDA | 4 | 13 | 37 | 9 | 6 | 49 | 8 | 7 | -1 | -5 | -3 | 1 | -1 | -0 | 5 | 2 | -6 | 3 | 1 | -3 | 3 | 2 | 6 | 5 |
| Operating Profit % | 11 % | 43 % | 39 % | 13 % | 14 % | 39 % | 13 % | 11 % | -7 % | -22 % | -13 % | -3 % | -16 % | -14 % | 4 % | -19 % | -26 % | -12 % | -8 % | -15 % | 4 % | -2 % | 9 % | 8 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 |
| Profit Before Tax | 3 | 13 | 36 | 9 | 5 | 49 | 8 | 6 | -2 | -5 | -4 | 0 | -2 | -1 | 4 | 1 | -7 | 3 | -0 | -3 | 2 | 1 | 5 | 5 |
| Tax | 1 | 3 | 9 | 2 | 1 | 13 | 2 | 2 | -1 | -1 | -1 | 0 | -0 | -0 | 1 | 1 | -2 | 1 | 0 | -1 | -0 | 0 | 1 | 1 |
| Net Profit | 2 | 9 | 27 | 6 | 4 | 36 | 5 | 5 | -1 | -4 | -3 | 0 | -2 | -1 | 3 | 0 | -4 | 2 | -1 | -3 | 3 | 1 | 4 | 4 |
| EPS in ₹ | 3.40 | 13.50 | 38.19 | 8.53 | 4.56 | 36.20 | 5.43 | 4.73 | -1.40 | -4.13 | -2.89 | 0.30 | -1.53 | -0.71 | 2.90 | 0.16 | -4.15 | 1.66 | -0.48 | -2.80 | 2.47 | 0.81 | 3.63 | 3.91 |
Nureca
Nureca
276.95
+2.55
(0.93%)
Market Cap
276.95 Cr
PE Ratio
24.70
Volume
11,447.00
Day High - Low
285.00 - 271.95
52W High-Low
343.00 - 203.62
Key Fundamentals
Market Cap
276.95 Cr
EPS
0.85
PE Ratio
24.70
PB Ratio
1.33
Book Value
207.77
EBITDA
4.90
Dividend Yield
0.00 %
Industry
Healthcare Sector
Medical Equipment Return on Equity
0.44
Debt to Equity
0.02
Actual
Company News
View All News
Nureca Limited's promoter group shareholding increased from 64.97% to 68.09% following completion of share buyback program that concluded on December 24, 2025.
Nureca Limited reported strong Q3FY26 performance with revenue rising 45.7% YoY to ₹396.40 crores. The company swung to profitability with net profit of ₹32.31 crores versus loss of ₹32.89 crores in Q3FY25.
Nureca Limited reports strong Q3 FY26 performance with revenue jumping 50% YoY to ₹396 million. EBITDA grows 314% to ₹54 million while PAT turns positive at ₹32 million vs ₹33 million loss in Q3 FY25.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,589.40 | #1 16,110.08 | 40.64 | #1 1,759.00 | 22.62 | #1 339 | 5.03 | 23.67 | |
204.93 | 1,126.34 | 39.52 | 242.40 | 24.12 | 25 | 44.07 | 17.86 | |
203.02 | 1,080.19 | 49.52 | 408.40 | 32.64 | 30 | -67.96 | 26.24 | |
601.65 | 1,043.07 | 67.48 | 173.30 | - | 15 | -14.81 | 54.76 | |
468.00 | 828.11 | 39.34 | 186.60 | 40.62 | 20 | - | 34.03 | |
155.35 | 690.54 | #1 15.67 | 335.90 | 45.66 | 47 | -211.76 | 28.38 | |
450.00 | 540.10 | 26.59 | 67.10 | 13.15 | 18 | 14.58 | 40.35 | |
268.00 | 510.27 | 31.06 | 136.30 | #1 107.77 | 16 | - | 44.04 | |
290.05 | 378.14 | 44.67 | 111.80 | - | 8 | - | 48.31 | |
276.95 | #10 276.95 | #2 24.70 | #8 122.10 | #7 19.24 | #10 1 | #1 232.14 | 41.58 |
Growth Rate
Revenue Growth
19.24 %
Net Income Growth
-144.44 %
Cash Flow Change
-604.06 %
ROE
-147.31 %
ROCE
-222.86 %
EBITDA Margin (Avg.)
1,236.67 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 24 | 34 | 186 | 219 | 207 | 205 | 210 |
| Fixed Assets | 1 | 1 | 4 | 10 | 9 | 7 | 9 |
| Current Assets | 23 | 33 | 181 | 206 | 187 | 193 | 190 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 33 | 59 | 94 | 1 |
| Other Assets | 23 | 33 | 182 | 175 | 139 | 104 | 200 |
| Total Liabilities | 24 | 34 | 186 | 219 | 207 | 205 | 210 |
| Current Liabilities | 15 | 10 | 19 | 12 | 9 | 9 | 12 |
| Non Current Liabilities | 0 | 9 | 4 | 4 | 3 | 3 | 3 |
| Total Equity | 8 | 15 | 163 | 203 | 195 | 193 | 194 |
| Reserve & Surplus | 8 | 15 | 153 | 193 | 185 | 183 | 184 |
| Share Capital | 0 | 0 | 10 | 10 | 10 | 10 | 10 |
Cash Flow
| Cash Flow | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 17 | -9 | -8 | 14 | -11 |
| Investing Activities | -0 | -0 | -110 | -3 | -17 | 18 | 8 |
| Operating Activities | 0 | -8 | 35 | 1 | 10 | -3 | -19 |
| Financing Activities | -0 | 8 | 92 | -7 | -2 | -1 | -0 |
Share Holding
| % Holding | Jan 2020 | Feb 2021 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Jan 2026 |
| Promoter | 93.33 % | 70.00 % | 70.00 % | 70.00 % | 70.00 % | 70.00 % | 70.00 % | 70.00 % | 70.00 % | 62.98 % | 62.98 % | 62.98 % | 63.24 % | 63.24 % | 63.24 % | 63.24 % | 63.77 % | 64.06 % | 64.30 % | 64.33 % | 64.97 % | 64.97 % | 68.09 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.10 % | 0.00 % | 0.08 % | 0.08 % | 0.69 % | 0.36 % | 1.07 % | 0.08 % | 0.08 % | 0.08 % | 0.08 % |
| DIIs | 0.00 % | 3.54 % | 5.71 % | 5.40 % | 5.42 % | 5.43 % | 5.23 % | 5.23 % | 0.58 % | 0.03 % | 0.02 % | 0.02 % | 0.02 % | 0.00 % | 0.02 % | 0.04 % | 0.04 % | 0.04 % | 0.04 % | 0.04 % | 0.04 % | 0.04 % | 0.04 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 5.87 % | 4.49 % | 4.32 % | 5.50 % | 5.18 % | 8.49 % | 8.54 % | 25.85 % | 34.17 % | 34.06 % | 34.24 % | 34.32 % | 33.61 % | 33.73 % | 34.24 % | 32.97 % | 33.27 % | 32.39 % | 33.12 % | 32.15 % | 32.95 % | 29.73 % |
| Others | 6.67 % | 20.59 % | 19.80 % | 20.28 % | 19.07 % | 19.40 % | 16.29 % | 16.23 % | 3.57 % | 2.82 % | 2.94 % | 2.76 % | 2.33 % | 3.16 % | 2.94 % | 2.41 % | 2.53 % | 2.27 % | 2.20 % | 2.45 % | 2.77 % | 1.97 % | 2.06 % |
| No of Share Holders | 19 | 8,436 | 7,827 | 10,060 | 12,618 | 15,471 | 26,123 | 26,114 | 63,911 | 62,007 | 58,560 | 55,569 | 52,255 | 49,600 | 45,996 | 43,813 | 41,986 | 41,314 | 39,304 | 38,075 | 37,468 | 35,801 | 35,800 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 2 | 3 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 1 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 23 Sept 2021 |  Dividend | ₹ 2.00 /share | 21 Sept 2021 | 1,549.00 | 1,634.10 |
| 25 Feb 2022 | Dividend | ₹ 3.00 /share | 24 Feb 2022 | 1,591.15 | 1,300.35 |
| 18 Jul 2024 |  Annual General Meeting | NA | 18 Jul 2024 | 277.90 | 275.50 |
| 24 Oct 2024 |  Quarterly Result Announcement | NA | 24 Oct 2024 | 299.65 | 299.35 |
| 24 Jan 2025 | Quarterly Result Announcement | NA | 24 Jan 2025 | 389.15 | 360.70 |
| 05 May 2025 | Quarterly Result Announcement | NA | 05 May 2025 | 248.00 | 228.80 |
| 16 Jun 2025 | Annual General Meeting | NA | 16 Jun 2025 | 228.80 | 279.00 |
| 15 Jul 2025 | Quarterly Result Announcement | NA | 15 Jul 2025 | 285.40 | 288.80 |
| 16 Oct 2025 | Quarterly Result Announcement | NA | 16 Oct 2025 | 229.70 | 235.45 |
| 18 Dec 2025 |  Buyback | 330 | 12 Dec 2025 | 285.40 | 282.30 |
| 17 Jan 2026 | Quarterly Result Announcement | NA | 17 Jan 2026 | 282.80 | 310.95 |
Announcements
Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011
3 days ago
3 days agoDisclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 20116 days ago
6 days agoDisclosures under Reg. 10(6) of SEBI (SAST) Regulations 20116 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Newspaper PublicationJan 20, 2026
Jan 20, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 19, 2026
Jan 19, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJan 18, 2026
Jan 18, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJan 17, 2026
Jan 17, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 17, 2026
Jan 17, 2026Board Meeting Outcome for Nureca Limited Has Informed The Exchange Regarding Financial Results For The Quarter Ended 31St December2025.Jan 17, 2026
Jan 17, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 15, 2026
Jan 15, 2026Board Meeting Intimation for Declaration Of Financial Results And Other Business Matters .Jan 10, 2026
Jan 10, 2026Extinguishment Of Equity Shares Bought Back.Jan 10, 2026
Jan 10, 2026Nureca Limited Has Informed The Exchange Regarding
Warning Letter.Jan 07, 2026
Jan 07, 2026Announcement under Regulation 30 (LODR)-Post Buyback Public AnnouncementJan 01, 2026
Jan 01, 2026Closure of Trading WindowDec 31, 2025
Dec 31, 2025Letter of OfferDec 16, 2025
Dec 16, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 11, 2025
Dec 11, 2025Announcement under Regulation 30 (LODR)-Change in Registered Office AddressDec 10, 2025
Dec 10, 2025Announcement Under Regulation 30 (LODR)Dec 03, 2025
Dec 03, 2025Announcement under Regulation 30 (LODR)-Public Announcement-Buyback of SharesDec 02, 2025
Dec 02, 2025Corporate Action-Buy backNov 28, 2025
Nov 28, 2025Corporate Action- Fixes Record Date For Buyback Of SharesNov 28, 2025
Nov 28, 2025Board Meeting Outcome for Nureca Limited Has Informed The Exchange Regarding Outcome Of Board Meeting Held On November 282025.Nov 28, 2025
Nov 28, 2025Closure of Trading WindowNov 25, 2025
Nov 25, 2025Board Meeting Intimation for Nureca Limited Has Informed The Exchange Regarding Intimation Of Board Meeting To Be Held On 28Th November 2025.Nov 25, 2025
Nov 25, 2025Nureca Limited Has Informed The Exchange Regarding Postponement Of Board Meeting Scheduled To Be Held On 10Th November 2025Nov 09, 2025
Nov 09, 2025Intimation Of Withdrawal Of Resignation Of Chief Financial Officer In Terms Of Regulation 30 Of SEBI(Listing Obligations And Disclosure Requirements) Regulations 2015.Nov 06, 2025
Nov 06, 2025Closure of Trading WindowNov 06, 2025
Nov 06, 2025Board Meeting Intimation for Proposal For Buyback Of Equity Shares Of The CompanyNov 05, 2025
Nov 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 17, 2025
Oct 17, 2025Intimation Of Securities And Exchange Board Of India (SEBI) Order Under Section 11(1) Of SEBI Act 1992 Read With Regulation 28 Of SEBI (Buy-Back Of Securities) Regulations 2018 (Buy-Back Regulations)Oct 17, 2025
Oct 17, 2025Nureca Limted Has Informed The Exchange Regarding Financial Results For The Quarter And Half Year Ended 30Th September2025.Oct 16, 2025
Oct 16, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 16, 2025
Oct 16, 2025Announcement under Regulation 30 (LODR)-Investor PresentationOct 16, 2025
Oct 16, 2025Board Meeting Outcome for Nureca Limited Has Informed The Exchange Regarding Financial Results For The Quarter And Half Year Ended 30Th September2025.Oct 16, 2025
Oct 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 15, 2025
Oct 15, 2025Announcement under Regulation 30 (LODR)-Change in ManagementOct 11, 2025
Oct 11, 2025Board Meeting Intimation for Nureca Limited Has Informed The Exchange Regarding Intimation Of Board Meeting For The Declaration Of Quarterly Results And Other Business Matters.Oct 10, 2025
Oct 10, 2025Closure of Trading WindowSep 29, 2025
Sep 29, 2025Filing Of Scheme Under Regulation 37(6) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Jul 24, 2025
Jul 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 16, 2025
Jul 16, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 15, 2025
Jul 15, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 15, 2025
Jul 15, 2025Board Meeting Outcome for Nureca Limited Has Informed The Exchange Regarding Unaudited Financial Results For The Quarter Ended 30Th June2025.Jul 15, 2025
Jul 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Jul 15, 2025Board Meeting Intimation for Declaration Of Unaudited Standalone/Consolidated Financial Results For The Quarter Ended June 302025 Alongwith Other Business Matters .Jul 09, 2025
Jul 09, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 08, 2025
Jul 08, 2025Closure of Trading WindowJun 28, 2025
Jun 28, 2025Closure of Trading WindowJun 28, 2025
Jun 28, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportJun 17, 2025
Jun 17, 2025Technical Indicators
RSI(14)
Neutral 41.58
ATR(14)
Volatile 15.27
STOCH(9,6)
Oversold 14.86
STOCH RSI(14)
Oversold 1.36
MACD(12,26)
Bearish -3.06
ADX(14)
Weak Trend 10.57
UO(9)
Bearish 41.08
ROC(12)
Downtrend And Accelerating -7.61
WillR(14)
Oversold -86.66
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
